Vital SignsVital SignsCheck your MP →
JRJulio Rosenstock, MD — no licensed photograph is available, so the academic plate is shown instead.

Academic

Julio Rosenstock, MD

Pivotal trial lead investigator at Velocity Clinical Research at Medical City in Dallas

Press citations

1

Topic

1

Diabetes

Last quoted

Sept 2026

Julio Rosenstock, MD: key facts

Kind of voice
Academic
Role
Pivotal trial lead investigator at Velocity Clinical Research at Medical City in Dallas
Quoted on
Diabetes
Press citations held
1
Most recently quoted
29 Sept 2026

“Onswik is designed to reduce injections by over 300 per year versus once-daily basal insulin”

Where Julio Rosenstock, MD has been quoted

  1. FDA Approves Efsitora Weekly Insulin for Type 2 Diabetesmedpagetoday.com · 29 Sept 2026

Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 29 Sept 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.